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Summary  Growing  numbers  of  healthcare  facilities  are  routinely  collecting  stan-
dardized  data  on  healthcare-associated  infection  (HAI),  which  can  be  used  not  only
to  track  internal  performance  but  also  to  compare  local  data  to  national  and  interna-
tional  benchmarks.  Benchmarking  overall  (crude)  HAI  surveillance  metrics  without
accounting  or  adjusting  for  potential  confounders  can  result  in  misleading  conclu-
sions.  Methods  commonly  used  to  provide  risk-adjusted  metrics  include  multivariate
logistic  regression  analysis,  stratiﬁcation,  indirect  standardization,  and  restrictions.
The  characteristics  of  recognized  benchmarks  worldwide,  including  the  advantages
and  limitations  are  described.  The  choice  of  the  right  benchmark  for  the  data  from
the  Gulf  Cooperation  Council  (GCC)  states  is  challenging.  The  chosen  benchmark
should  have  similar  data  collection  and  presentation  methods.  Additionally,  dif-
ferences  in  surveillance  environments  including  regulations  should  be  taken  into
consideration  when  considering  such  a  benchmark.  The  GCC  center  for  infection
control  took  some  steps  to  unify  HAI  surveillance  systems  in  the  region.  GCC  hos-
pitals  still  need  to  overcome  legislative  and  logistic  difﬁculties  in  sharing  data  to
create  their  own  benchmark.  The  availability  of  a  regional  GCC  benchmark  may
better  enable  health  care  
realistic  comparisons.
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Introduction
Between  7  and  10%  of  patients  worldwide  admit-
ted to  acute  care  hospitals  develop  at  least  one
healthcare-associated  infection  (HAI)  during  their
hospital stay  [1]. HAIs  add  extra  morbidity  and
mortality  risks  to  patients  and  lead  to  consider-
able stretching  of  many  countries’  already  limited
healthcare  resources  [1—3]. Recently,  HAI  surveil-
lance as  part  of  a  broad-based  prevention  and
control strategy  has  received  more  attention  from
healthcare  facilities,  patient-safety  organizations,
and patients  themselves  [4].  Growing  numbers  of
healthcare  facilities  are  routinely  collecting  stan-
dardized  data  on  HAIs,  which  are  used  not  only
to track  internal  performance  but  also  to  compare
local data  to  national  and  international  benchmarks
[4].
Benchmarking
Prior  to  its  use  in  healthcare  surveillance,  bench-
marking was  recognized  in  industry  as  an  effective
means of  improving  business  performance  [5].
Today, HAI  benchmarking  can  be  divided  into  inter-
nal and  external  systems.  Internal  benchmarking
typically involves  comparing  current  processes
and/or outcomes  to  baseline  data  or  comparing
different departments  in  the  same  healthcare  facil-
ity [6].  Although  easily  accessible  and  potentially
highly useful,  the  collection  of  baseline  data  that
is of  adequate  size  for  statistical  comparison  may
require  a  signiﬁcant  amount  of  time.  Moreover,
the inability  to  adjust  for  patient,  healthcare,  and
methodological  changes  over  time  may  lead  to  erro-
neous conclusions.  External  benchmarking,  on  the
other hand,  usually  involves  comparing  processes
and/or outcomes  in  one  healthcare  facility  to  other
facilities  performing  similar  activities,  often  with
higher standards  [7]. The  main  challenge  to  exter-
nal benchmarking  is  accounting  for  differences  in
patient risks  and  surveillance  methodologies.
The  purpose  of  both  internal  and  external  bench-
marking is  to  continuously  improve  healthcare  by
demonstrating  strengths  and  weaknesses,  stimu-
lating competitiveness,  and  assessing  the  value  of
interventions  intended  to  reduce  HAIs  [6]. Bench-
marking  is  often  compromised  by  the  limitation
of simply  comparing  outcome  indicators  rather
than analyzing  and  promoting  the  best  practices
[8].  Without  performing  these  latter  activities,  the
benchmarking  of  HAI  data  can  be  misleading.  Fur-
thermore,  the  benchmarked  data  must  be  collected
using standardized  case  deﬁnitions  as  well  as  sim-
ilar data  collection  methods  and  in  populations
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f  adequate  sizes  over  a  sufﬁcient  duration  of
ime, as  a statistically  relevant  number  of  out-
omes are  required  for  comparison  [9]. Moreover,
he collected  data  should  be  analyzed  and  reported
sing similar  risk-stratiﬁed  or  risk-adjusted  metrics
rates, proportions,  or  ratios)  to  allow  fair  com-
arisons  [9].  Nevertheless,  benchmarking  is often
erformed  without  fulﬁlling  these  conditions,  per-
aps because  local  policy  makers  poorly  understand
he signiﬁcance  of  these  limitations.  Obviously,
xternal benchmarking  cannot  be  accomplished  if
here is  no  regional  system  for  data  collection  and
issemination.
enchmarking risk-adjusted metrics
ne  of  the  major  challenges  in  benchmarking
etrics  of  HAI  surveillance  is  the  heterogeneity
f healthcare  facilities  in  terms  of  HAI  risk.  The
otential  for  healthcare  facilities  to  report  higher
ates of  HAIs  is  dependent  on  many  factors  includ-
ng size  (bed  number)  of  the  facility,  type  and
omplexity of  the  care  provided  (such  as  burn
are and  solid  organ  transplants),  length  of  patient
tay, duration  and  type  of  device  use,  patient
isks for  an  HAI  (such  as  age  and  immunocom-
romising  conditions),  and  comorbidities  (such  as
enal dysfunction,  liver  failure,  obesity,  and  dia-
etes) [10—13]. Therefore,  benchmarking  overall
crude) HAI  surveillance  metrics  without  accounting
r adjusting  for  these  variables  can  result  in  mis-
eading  conclusions.  Providing  risk-adjusted  metrics
s one  way  to  reduce  the  possibility  of  such  erro-
eous  conclusions  [4]. Statistical  adjustments  of
he metric  can  take  any  of  the  following  forms:  (1)
ultivariate  logistic  regression  analysis  to  adjust
or multiple  confounders  at  the  same  time;  (2)
tratiﬁcation  to  adjust  for  (usually)  one  confounder
t a  time  by  stratifying  the  metric  by the  levels
groups) of  that  confounder;  (3)  standardization
o adjust  for  (usually)  one  confounder  based  on
eighted  averages;  or  (4)  restrictions  to  adjust  for
usually) one  confounder  by  excluding  unwanted
evels of  that  confounder.
Stratiﬁcation  is  by  far  the  most  common  adjust-
ent method  used  in  benchmark  reports.  The
ational Healthcare  Safety  Network  (NHSN)  and
he International  Nosocomial  Infection  Control  Con-
ortium (INICC)  previously  reported  type-speciﬁc
ates of  device-associated  HAI  stratiﬁed  by  crit-
cal care  unit  types  for  adults  and  paediatric
atients and  by  weight  groups  for  neonatal  patients
2,14]. Additionally,  dialysis  access-related  infec-
ions were  stratiﬁed  according  to  the  type  of
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(enchmarking  local  healthcare-associated  infection
ascular  access  [15], and  procedure-speciﬁc  surgi-
al site  infection  (SSI)  rates  (actual  proportions)
ere stratiﬁed  according  to  the  NHSN  risk  index
ategory, which  is  based  on  the  American  Society
f Anesthesiologists’  scores,  procedure  duration,
nd wound  classiﬁcation  [16].  Although  stratiﬁca-
ion is  a  straightforward  and  powerful  method  of
djustment,  the  question  remains  whether  studies
se the  correct  levels  of  stratiﬁcation.  For  exam-
le, it  was  shown  that  procedure-speciﬁc  stepwise
ogistic regression  models  for  SSI  data  yielded  new
rocedure-speciﬁc  risk  factors  that  were  more  pre-
ictive than  the  current  risk  index  category  [17].
nother potential  problem  with  stratiﬁcation  is  that
s the  rate  of  HAI  decreases,  small  units  (such  as
oronary  care  units)  may  have  too  few  outcomes
o allow  statistically  meaningful  comparisons  over
 speciﬁed  time  (usually  one  month).
Multivariate  regression  adjustment  and  indirect
tandardization are  increasingly  used  in  reporting
AI surveillance  metrics.  A  number  of  studies  have
djusted  HAI  prevalence  and  antimicrobial  use  for
he case-mix  (i.e.,  heterogeneity  regarding  the
atient’s  risk)  using  multivariate  logistic  regression
odels  and  an  indirect  standardization  method  to
llow for  fair  inter-hospital  comparisons  [11,18,19].
pproximately  two  decades  ago,  the  National
osocomial Infections  Surveillance  (NNIS)  system
ntroduced  the  standardized  infection  ratio  (SIR)
o indirectly  standardize  SSI  rates  using  a  standard
opulation to  enable  fair  comparisons  of  SSI  rates
etween  a  healthcare  facility  and  a  benchmark  with
 different  risk  index  category  [20].  Recently,  the
HSN promoted  the  expansion  of  SIR  use  to  report
 single  SIR  for  a  speciﬁed  device-associated  HAI
rom multiple  hospital  locations  (such  as  specialty
are areas)  to  adjust  for  differences  in HAI  inci-
ence  between  these  locations  [21].  However,  a
ecent report  expressed  doubts  about  the  reliabil-
ty and  consistency  of  SIR  compared  to  stratiﬁed  HAI
ates and  showed  that  SIR  may  obscure,  amplify,  or
everse differences  between  two  or  more  health-
are facilities  and  a  benchmark  due  to  its  inherent
ependence on  the  changes  in  risk-strata  of  both
ealthcare  facilities  and  benchmark  populations
22].
enchmark reports
enchmarks  are  typically  public  reports  that  apply
 standard  methodology  and  estimate  risk-stratiﬁed
r risk-adjusted  HAIs  and/or  their  preventive
rocesses across  a  large  network  of  healthcare
acilities. Recognized  benchmarks  for  HAI  include
he NHSN  [23],  INICC  [24], European  Centre  for325
isease  Prevention  and  Control  (ECDC),  and  World
ealth  Organization  (WHO)  estimates  [1]. The  char-
cteristics  of  these  four  benchmarks,  including  the
dvantages  and  limitations,  are  shown  in  Table  1.
1) NHSN  reports:  NHSN  is  a secure,  internet-
based surveillance  system  at  the  US  Centers
for Disease  Control  and  Prevention  (CDC)  [23].
It was  established  in  2005  to  integrate  and
replace three  different  surveillance  systems  at
the CDC,  including  the  NNIS,  and  NHSN  is  by
far the  most  important  and  well-established
surveillance  system  worldwide.  One  of  its  main
stated purposes  is  to  provide  enrolled  facili-
ties with  risk-adjusted  metrics  that  can  be  used
for inter-facility  comparisons  and  local  qual-
ity improvement  activities.  Starting  in  2007,
NHSN published  a yearly  report  to  estimate
the magnitude  of  HAI,  mainly  in  regards  to
risk-stratiﬁed pooled  means  and  percentiles
of device-associated  and  procedure-associated
HAIs  [14,16]. However,  ignoring  non-device-
associated  pneumonia,  bloodstream  infections,
and urinary  tract  infections  as  well  as  some
surgeries limits  the  comprehensiveness  of  the
NHSN surveillance  system  [25].  The  last  antimi-
crobial resistance  report  was  published  by
NNIS in  2004  [26], pointing  to  the  infre-
quency of  reporting  for  some  NHSN  modules.
NHSN is  widely  used  as  a  benchmark  even
outside of  the  US  because  its  surveillance
methodology  is  implemented  in  many  hospi-
tals worldwide.  However,  frequent  changes
in NHSN  deﬁnitions,  especially  for  catheter-
associated urinary  tract  infection  (CAUTI),
dialysis events,  antimicrobial  use,  and  neonatal
central line  associated  bloodstream  infection
(CLABSI), make  it  difﬁcult  for  any  health-
care facility  outside  the  NHSN  to  interpret
the results  of  their  benchmarking  if  they
do not  incorporate  these  changes  into  their
own surveillance  system  on  a timely  basis
[27—29]. Approximately  90%  of  enrolled  hos-
pitals are  general  hospitals,  including  acute,
trauma, and  teaching  facilities,  although  the
number  of  enrolled  hospitals  has  increased
sharply during  the  last  few  years  and  now
includes a larger  representation  of  smaller  hos-
pitals.
2) INICC  reports:  The  INICC  is  an  international
collaborative  HAI  surveillance  system  that  uses
a methodology  largely  similar  to  that  of  the
NHSN [24]. It  is  the  ﬁrst  international  research
network and  largest  of  its  type  outside  of  the
US. INICC  was  founded  in  Argentina  in  1998,
and the  ﬁrst  multinational  benchmark  report
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Table  1  Comparisons  of  the  characteristics  of  recognized  benchmarks.
NHSN  INICC  ECDC  WHO
Covered  countries US  36  countries  in  South  America,
Asia,  Africa,  and  Europe  in  2009
17  European  countries
Up  to  13  reported  SSIs
13  reported  ICU-acquired  HAIs
Systematic  review  of  published
data  from  23  high-  and  23
low-income  countries
Covered  years  2006—2010  2003—2009  2007—2009  1995—2010
Number  of  contributing
hospitals
Approximately  2500  in  last
report
215  in  last  report  1156  reported  SSIs
721  reported  ICU-acquired  HAIs
Not  deﬁned
Covered  location  for
device-associated  HAIs
ICU  and  non-ICU  locations ICU  only ICU  only ICU  only
HAI types  covered  SSI  and  device-associated  HAIs  Device-associated  HAIs  SSI  and  device-associated  HAIs  SSI  and  device-associated  HAIs
HAI  deﬁnition  used US  CDC  Similar  to  US  CDC  European  CDC  Mixed
Type of  device-associated
HAI  data
Unit-based  Unit-based  Unit-based  and  patient-based Mixed
Data entry  &  analysis  Individual  data  are  entered
locally  in  an  internet-based
surveillance  system  and  then
centrally  analyzed
Aggregate  data  are  received
from  enrolled  hospitals  and  then
centrally  analyzed
Individual  data  are  entered  in
standardized  national  networks,
and  then  data  from  all  networks
are centrally  analyzed
Systematic  review  and
meta-analysis  of  published  data
Advantages  •  Large  data  set  that  allows
multiple  stratiﬁcations
•  Uses  standardized  deﬁnitions
of  HAIs
• Reports  device-associated  HAIs
from  ICU  and  non-ICU  locations
• Electronic  data  entry
•  Covers  under-studied
limited-resource  countries
•  Uses  standardized  deﬁnitions
of  HAIs
• Reports  HAI-related  mortality
and  length  of  stay  as  well  as
preventive  bundles
•  Large  data  set  that  allows
stratiﬁcations  and  adjustments
•  Collects  both  unit-based  and
patient-based  data
• Provides  some  data  adjusted
for  patient  risk
•  Electronic  data  entry
•  Good  crude  estimates  for  HAI
incidence,  prevalence,  and
impact
•  Covers  both  low-  and
high-income  countries
Limitations  •  Frequent  changes  in  deﬁnitions
and  methods
•  Reports  of  dialysis  infections
and  antimicrobial  use  are
infrequently  released
• No  adjustment  for  patient  risk
• Not  a  true  cohort,  which
epidemiologically  limits
comparing  data  over  time
• Ignores  non-device-associated
HAIs  such  as  non-ventilated
pneumonia
•  Validity  of  reported  data  is  not
determined
• Analyzes  aggregate  rather  than
individual  data
•  No  standardized  electronic
data  collection  in  enrolled
hospitals
•  No  single-year  data  to  examine
changes  over  time
• Hospitals  included  may  not
reﬂect  their  respective  countries
•  Lack  of  device-associated  HAIs
from  non-ICU  locations
• Currently  no  SSI  reports
•  No  adjustment  for  patient  risk
• Validity  of  reported  data  is  not
determined
• Although  standardized,
deﬁnitions  of  HAIs  are  not
followed  by  all  member
countries
• ECDC  deﬁnitions  are  not
popular  outside  of  European
countries
•  Frequent  changes  in
surveillance  systems  over  the
last  2  decades  limits  the
frequency  of  reports
•  Lack  of  device-associated  HAIs
from  non-ICU  locations
•  Only  7  surgeries  are  covered  in
SSI  reports
Validity  of  reported  data  is  not
determined
• Includes  studies  with
heterogonous  case  deﬁnitions  of
HAIs  and  methods
• Data  presented  are  neither
risk-stratiﬁed  nor  risk-adjusted
•  Data  from  low-income
countries  are  fragmented  and
may  not  represent  low-income
countries
B s  327
(
0
2
4
6
8
10
12
14
1990-
1996
1992-
1998
1995-
2000
1995-
2003
2002-
2004
2006 2006 -
2008
2009 201 0
Period  cove red
In
ci
de
nc
e 
pe
r 1
00
0 
de
vi
ce
-d
ay
s CLABS I
CAUTI 
VAP
Figure  1  Device-associated  HAIs  in  adult  medical-
surgical  ICUs*  of  NHSN  enrolled  hospitals.  *Data  from
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(released  in  2006)  reported  largely  South  Amer-
ican  data  [30].  Unlike  NHSN,  which  receives
locally entered  individual  data,  INICC  uses
aggregate data  received  from  enrolled  hospi-
tals that  are  summed  and  analyzed  centrally
[31].  Additionally,  data  on  device-associated
HAIs are  collected  from  patients  who  do
or do  not  develop  HAI,  allowing  for  com-
parisons of  mortality  and  length  of  stay.
Voluntary enrollment  in  INICC  has  dramatically
increased over  the  last  few  years,  and  the
2012 report  presented  data  from  215  hospi-
tals from  36  countries  in  South  America,  Asia,
Africa, and  Europe  [2]. In  addition,  almost
all of  the  enrolled  countries  are  considered
low-resources  countries,  and  the  enrolled  hos-
pitals  include  academic  teaching  (44%),  public
(35%),  and  private  community  (21%)  facilities
and likely  represent  the  elite  hospitals  in  their
respective countries.  Similar  to  the  NHSN,  the
INICC  reports  show  the  mean  and  percentiles  of
device-associated  HAI  rates  and  device  utiliza-
tion ratios  as  well  as  the  rates  of  antimicrobial
resistance.  Additionally,  these  reports  show
data on  related  mortality,  length  of  stay,  and
hand hygiene.
3) ECDC  reports:  The  ECDC  is  the  current  ofﬁ-
cial HAI  surveillance  system  in  the  European
Union (EU)  member  states.  ECDC  uses  the
Hospitals in  Europe  Link  for  Infection  Con-
trol through  Surveillance  (HELICS)  protocol
for SSI  and  ICU-acquired  infections  [32]. The
main objective  of  the  ECDC  is  to  create  an
EU benchmark  for  inter-hospital  comparisons
of HAI  rates,  microorganisms,  and  antimicro-
bial resistance.  In  2012  reports,  between  11
and 13  out  of  28  EU  member  states  con-
tributed data  for  device-associated  HAI  and
SSI, while  fewer  states  (n  = 6)  contributed  data
for antimicrobial  use  [33,34].  The  HELICS  pro-
tocol for  SSI  is quite  similar  to  the  NHSN
protocol, and  the  SSI  rate  is  stratiﬁed  using
the NHSN  risk-index  category.  Unlike  for  the
NHSN, the  SSI  rate  in  ECDC  reports  is  addi-
tionally expressed  per  1000  patient-days,  and
Poisson  regression  is  used  to  adjust  for  case-mix
deﬁned according  to  the  risk-index  category.
The HELICS  protocol  for  ICU-acquired  device-
associated HAI  is  quite  different  from  that
of NHSN,  as  it  collects  both  unit-based  data
(denominator)  and  patient-based  data  (risk  fac-
tors) in  patients  who  stayed  three  or  more
days in  the  ICU.  Additionally,  case  deﬁnitions,
particularly bloodstream  infections  and  pneu-
monia, differ  from  those  of  the  NHSN  [35].
Unlike  both  NNIS  and  INICC  reports  that  use
s
a
v
rifferent  types  of  adult  medical  surgical  ICUs  (major
eaching,  ≤15  beds,  and  >15  beds)  were  combined  when
tratiﬁed.
deﬁned  daily  use  of  antimicrobials  data  [26,36],
the ECDC  antimicrobial  use  data  are  pre-
sented as  the  number  of  treatment  days  for
a speciﬁc  antimicrobial  per  1000  patient-days,
and all  ICUs  are  typically  presented  together
[33].
4) WHO  HAI  estimates: The  WHO  HAI  estimates
are based  on  systematic  reviews  published  for
national  and  multi-national  data  from  both
high- and  low-resources  countries,  including
the three  benchmarks  mentioned  previously
[1].  Because  only  a  minority  (15.6%)  of
low-income countries  have  published  data
on HAI  incidence,  this  report  likely  does
not reﬂect  the  actual  HAI  situation  in  low-
income countries.  Moreover,  the  data  pre-
sented are  neither  risk-stratiﬁed  nor  risk-
adjusted. However,  the  report  can  be  viewed
as a reasonable,  albeit  crude,  source  of  esti-
mates for  HAI  incidence,  prevalence,  and
impact.
hoosing the right benchmark
he  recent  availability  of  benchmark  reports  from
ifferent  parts  of  the  world  has  widened  the  bench-
arking  options  for  new  hospitals  in  GCC  states.
 chosen  benchmark  should  have  similar  data  col-
ection and  presentation  methods,  although  the
election  of  the  right  benchmark  report  is  not
n easy  task,  particularly  when  there  are  wide
ariations in  HAI  incidence  between  benchmark
eports using  similar  methods  (Tables  2  and  3).
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For  example,  the  incidence  of  device-associated
HAI is two-  to  three-fold  higher  in  low-resources
countries than  in  high-resources  countries  (Table  2).
Additionally, even  within  high-resource  countries,
the incidence  of  SSIs  is  considerably  different,
as the  incidence  is  lower  in  the  NHSN  than  the
ECDC for  many  procedures  (Table  3).  Moreover,
the change  in  HAI  incidence  in  consecutive  reports
from the  same  benchmark  organization  (Fig.  1) and
the underlying  contributing  causes  may  complicate
the selection  and  interpretation  of  the  bench-
marking process  [14,16,26,37—42].  For  example,
several causes  that  may  affect  fair  comparisons
were hypothesized  to  explain  the  downward  trend
in device-associated  HAI  rates  in  consecutive  NHSN
reports,  including  (1)  changes  in  HAI  deﬁnitions  to
reduce the  percentage  of  non-objective  diagnoses
(e.g., abandoning  clinical  sepsis  as  an  accept-
able diagnosis  for  CALBSI);  (2)  complying  with
regulations for  mandatory  HAI  reporting  in  many
f
o
w
f
Table  2  Device-associated  HAIs  and  device  utilization  in  
reports.
CA-BSIa CLU  
NHSN  (2010)  1.1  (1.1—1.2)  0.45  
INICC  (2004—2009)  5.9  (5.7—6.2)  0.53  
ECDC  (2007)  3.2  0.69  
WHO,  High-resource
countries  (1995—2010)b
3.5  (2.8—4.1)  NA  
WHO,  Low-resource  countries
(1995—2010)b
12.2  (10.5—13.9)  NA  
a Central line-associated, rather than catheter, in the NHSN and I
ECDC rates included primary and secondary BSIs.
b WHO estimates were from all types of adult ICUs and included 
Table  3  Incidence  of  SSIs  per  100  operations  for  selec
(2008—2009).
R
0
Coronary  artery  bypass  graft NHSN  0
ECDC  2
Cholecystectomy NHSN  0
ECDC  0
Colon  surgery NHSN 4
ECDC  7
Caesarean  section NHSN  1
ECDC  3
Hip  prosthesis NHSN  0
ECDC  0
Knee  prosthesis NHSN 0
ECDC  0
Laminectomy NHSN  0
ECDC  1A.  El-Saed  et  al.
tates  (this  represented  70%  of  contributing  hos-
itals in  the  2010  data);  (3)  enrollment  of  many
ospitals  with  smaller  bed  numbers,  which  gen-
rally have  a lower  risk  of  HAIs  (this  represented
wo-thirds of  contributing  hospitals  in  the  2010
ata); and  (4)  implementation  of  multiple  infec-
ion control  strategies  by  many  hospitals,  which
ay have  resulted  in  an  actual  decrease  in  HAI  inci-
ence.
enchmarking local data
enchmarking  local  GCC  data  is  challenging,
lthough benchmarking  to  NHSN  reports  is  pre-
erred  because  the  case  deﬁnitions  and  method-
logies are  similar  and  differences  in  HAI  rates
ill likely  encourage  improvements.  However,  dif-
erences in  surveillance  environments,  including
adult  medical-surgical  ICUs  in  recognized  benchmark
CA-UTI  UCU  VAP  VU
1.5  (1.4—1.5)  0.68  1.3  (1.2—1.4)  0.32
7.1  (6.9—7.3)  0.56  18.4  (17.9—18.8)  0.38
6.5  0.77  13.4  0.54
4.1  (3.7—4.6)  NA  7.9  (5.7—10.1)  NA
8.8  (7.4—10.3)  NA  23.9  (20.7—27.1)  NA
NICC reports. We excluded clinical sepsis from the INICC rate.
both catheter-related and -associated BSIs and UTIs.
ted  operations  in  the  NHSN  (2006—2008)  and  ECDC
isk  index  category  Overall
 1  2  &  3
.4  2.6  4.3  2.9
.6  3.3  4.4  3.3
.2  0.6  1.7  0.6
.9  1.9  4.5  1.4
.0  5.6  7.3  5.5
.2  9.5  13.7  10.0
.5  2.4  3.8  1.8
.5  3.7  3.8  3.6
.7  1.4  2.4  1.3
.7  1.7  2.7  1.2
.6  1.0  1.6  0.9
.6 1.1  1.9  0.8
.7  1.1  2.3  1.0
.0  2.1  3.7  1.3
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[enchmarking  local  healthcare-associated  infection
egulations  in  GCC  and  NHSN  hospitals,  should  be
aken into  consideration.  Additionally,  delays  in
mplementing  frequent  NHSN  changes  in  case  deﬁ-
itions and  methodologies  could  further  complicate
nterpretation of  the  data.  Benchmarking  to  INICC
eems  legitimate  because  of  similar  methodologies
nd challenges,  as  well  as  the  availability  of  unique
ata on  mortality,  length  of  stay,  and  prevention.
owever, the  use  of  aggregate  data  from  enrolled
ospitals does  not  account  for  the  variability  in
urveillance  adjudication  between  and  within  par-
icipating  countries.  Moreover,  the  benchmarking
rocess is  expected  to  improve  infection  control
ractices when  using  a  benchmark  of  a  higher
tandard. ECDC  may  be  an  alternative  benchmark
o GCC  hospitals  for  SSIs  and  antimicrobial  use  and
esistance.  However,  the  considerable  differences
n device-associated  HAI  deﬁnitions  likely  limit  its
se as  a  benchmark  for  that  purpose.  WHO  esti-
ates for  high-resources  countries  are  driven  by
HSN and  ECDC  data,  while  the  estimates  for  low-
esources  countries  are  largely  fragmented  and  not
erived from  a  clear  source.  Additionally,  failure
o account  for  the  wide  variability  in  surveillance
ethods implemented  in  different  parts  of  the
orld,  as  well  as  failure  to  risk-stratify  different
etrics of  HAI,  limits  the  beneﬁt  of  the  WHO  esti-
ates as  a  benchmark.  The  GCC  center  for  infection
ontrol  distributed  its  second  edition  of  the  GCC
urveillance  manual  in  2011  and  has  conducted
any surveillance  training  activities  to  unify  HAI
urveillance  systems  in  the  region.  However,  GCC
ospitals  still  need  to  overcome  legislative  and
ogistic  difﬁculties  in  sharing  data  to  create  their
wn benchmark.  The  availability  of  a  regional  GCC
enchmark  that  addresses  many  of  the  above  chal-
enges may  better  enable  health  care  workers  and
esearchers  to  obtain  more  accurate  and  realistic
omparisons and  may  positively  impact  infection
ontrol standards  and  patient  safety  in  the  region.
unding
o  funding  sources.
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